5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.84▲ | 0.84▲ | 0.84▲ | 0.96▼ | 1.20▼ |
MA10 | 0.83▲ | 0.82▲ | 0.83▲ | 1.14▼ | 1.31▼ |
MA20 | 0.82▲ | 0.82▲ | 0.84▲ | 1.22▼ | 1.42▼ |
MA50 | 0.83▲ | 0.95▼ | 1.10▼ | 1.35▼ | 1.60▼ |
MA100 | 0.86▼ | 1.13▼ | 1.17▼ | 1.44▼ | 2.22▼ |
MA200 | 1.07▼ | 1.24▼ | 1.34▼ | 1.47▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.007▲ | 0.016▲ | 0.020▲ | -0.049▼ | -0.031▼ |
RSI | 68.367▲ | 50.514▲ | 37.778▼ | 26.308▼ | 31.326▼ |
STOCH | 97.923▲ | 81.481▲ | 53.425 | 30.470 | 23.987 |
WILL %R | 0.000▲ | 0.000▲ | -0.434▲ | -85.781▼ | -91.250▼ |
CCI | 150.115▲ | 184.382▲ | 138.669▲ | -132.345▼ | -196.746▼ |
Thursday, September 25, 2025 05:17 AM
Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously ...
|
Thursday, September 25, 2025 05:14 AM
Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing ...
|
Wednesday, September 24, 2025 05:23 AM
The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochlear Implant OpportunitySix-month follow-up visits are now underway and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/09/25 | 0.83 | 0.888 | 0.815 | 0.851 | 189,107 |
24/09/25 | 0.8501 | 0.90 | 0.76 | 0.8278 | 424,523 |
23/09/25 | 0.95 | 0.9619 | 0.7693 | 0.8501 | 1,141,274 |
22/09/25 | 1.10 | 1.25 | 0.8885 | 0.9445 | 1,689,652 |
19/09/25 | 1.34 | 1.40 | 1.3004 | 1.31 | 266,951 |
18/09/25 | 1.32 | 1.3839 | 1.32 | 1.37 | 19,195 |
17/09/25 | 1.34 | 1.39 | 1.32 | 1.32 | 47,800 |
16/09/25 | 1.32 | 1.35 | 1.32 | 1.34 | 11,655 |
15/09/25 | 1.31 | 1.34 | 1.28 | 1.33 | 33,192 |
12/09/25 | 1.30 | 1.35 | 1.2643 | 1.29 | 60,164 |
|
|
||||
|
|
||||
|
|